AR012417A1 - COMPOSICIoN FARMACÉUTICA DE ADMINISTRACIoN ORAL Y PROCEDIMIENTO PARA SU PRODUCCION. - Google Patents

COMPOSICIoN FARMACÉUTICA DE ADMINISTRACIoN ORAL Y PROCEDIMIENTO PARA SU PRODUCCION.

Info

Publication number
AR012417A1
AR012417A1 ARP980101703A ARP980101703A AR012417A1 AR 012417 A1 AR012417 A1 AR 012417A1 AR P980101703 A ARP980101703 A AR P980101703A AR P980101703 A ARP980101703 A AR P980101703A AR 012417 A1 AR012417 A1 AR 012417A1
Authority
AR
Argentina
Prior art keywords
procedure
production
pharmaceutical composition
oral administration
acting
Prior art date
Application number
ARP980101703A
Other languages
English (en)
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of AR012417A1 publication Critical patent/AR012417A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

Se refiere a preparado medicinal de administracion oral que contiene una combinacion fija de al menos un analgésico de accion local con comienzorápido del efecto y al menos un analgésico de accion sistémica con efecto prolongado y unpro cedimiento para su produccion.
ARP980101703A 1997-04-15 1998-04-14 COMPOSICIoN FARMACÉUTICA DE ADMINISTRACIoN ORAL Y PROCEDIMIENTO PARA SU PRODUCCION. AR012417A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19715594A DE19715594A1 (de) 1997-04-15 1997-04-15 Analgetika-Kombination

Publications (1)

Publication Number Publication Date
AR012417A1 true AR012417A1 (es) 2000-10-18

Family

ID=7826504

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980101703A AR012417A1 (es) 1997-04-15 1998-04-14 COMPOSICIoN FARMACÉUTICA DE ADMINISTRACIoN ORAL Y PROCEDIMIENTO PARA SU PRODUCCION.

Country Status (24)

Country Link
US (1) US6929805B2 (es)
EP (1) EP0979087B1 (es)
JP (1) JP2002503221A (es)
KR (1) KR100532647B1 (es)
CN (1) CN1177589C (es)
AR (1) AR012417A1 (es)
AT (1) ATE253919T1 (es)
AU (1) AU742622B2 (es)
BR (1) BR9808875A (es)
CA (1) CA2285979C (es)
DE (2) DE19715594A1 (es)
DK (1) DK0979087T3 (es)
ES (1) ES2210754T3 (es)
HK (1) HK1027505A1 (es)
HU (1) HU225601B1 (es)
NO (1) NO323022B1 (es)
NZ (1) NZ500262A (es)
PL (1) PL190863B1 (es)
PT (1) PT979087E (es)
RS (1) RS49620B (es)
RU (1) RU2218180C2 (es)
TR (1) TR199902396T2 (es)
WO (1) WO1998046235A1 (es)
YU (1) YU52999A (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6423697B1 (en) * 1999-01-14 2002-07-23 Mark Friedman Intraoral topical anti-inflammatory treatment for relief of migraine, tension-type headache, post-traumatic headache, facial pain, and cervical-muscle spasm
AU1713501A (en) * 1999-11-23 2001-06-04 Robert Gordon University, The Bilayered buccal tablets comprising nicotine
AU3162001A (en) * 1999-12-21 2001-07-03 Id-Pharma Gmbh Medicament, a method for its production and the use thereof
KR20010069756A (ko) * 2001-05-08 2001-07-25 유형선 소염진통제인 아세메타신을 함유하며 장관내 특히대장에서의 약물 방출 속도가 조절되는 약물 전달 체계에대한 약제학적 경구용 조성물 및 그에 대한 제조방법
US20030035839A1 (en) * 2001-05-15 2003-02-20 Peirce Management, Llc Pharmaceutical composition for both intraoral and oral administration
US6863901B2 (en) 2001-11-30 2005-03-08 Collegium Pharmaceutical, Inc. Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration
US6827946B2 (en) 2001-12-05 2004-12-07 Collegium Pharmaceutical, Inc. Compositions containing both sedative and non-sedative antihistamines
DE102004001093A1 (de) * 2004-01-05 2005-07-28 Liedtke, Rainer K., Dr. Zusammensetzung und Methode einer synergistischen topischen Therapie neuromuskulärer Schmerzen
DE102004040630A1 (de) * 2004-08-21 2006-03-09 Balaban, Romulus, Dr.med. Kombinationstherapie mit Procain
WO2008105920A1 (en) * 2007-02-28 2008-09-04 Collegium Pharmaceutical, Inc. Antihistamine combination
DE102008007212B3 (de) 2008-02-01 2009-10-15 BSH Bosch und Siemens Hausgeräte GmbH Gehäuse für den Antrieb eines elektrischen Geräts, insbesondere eines Haushaltsgeräts
US8231588B2 (en) * 2008-08-01 2012-07-31 Tian Xia Methods for ameliorating pain and devices for delivering a medicament
US8690839B2 (en) 2008-08-01 2014-04-08 Tian Xia Devices for delivering a medicament and connector for same
US8905980B2 (en) 2008-08-01 2014-12-09 Tian Xia Devices for delivering a medicament and methods for ameliorating pain
US20130049932A1 (en) * 2011-08-25 2013-02-28 Elwha LLC, a limited liability company of the State of Delaware Systems, devices, methods, and admixtures of transponders and food products for indication of food attributes
US10016580B2 (en) 2013-12-17 2018-07-10 Biovision Technologies, Llc Methods for treating sinus diseases
US9694163B2 (en) 2013-12-17 2017-07-04 Biovision Technologies, Llc Surgical device for performing a sphenopalatine ganglion block procedure
US9516995B2 (en) 2013-12-17 2016-12-13 Biovision Technologies, Llc Surgical device for performing a sphenopalatine ganglion block procedure
US9510743B2 (en) 2013-12-17 2016-12-06 Biovision Technologies, Llc Stabilized surgical device for performing a sphenopalatine ganglion block procedure
DE102015114799A1 (de) * 2015-09-04 2017-03-09 Knorr-Bremse Systeme für Nutzfahrzeuge GmbH Druckmittelaggregat, mit einem durch Spritzgießen hergestellten Gehäuse aus Kunststoff sowie Verfahren zu seiner Herstellung
WO2019064090A1 (en) * 2017-09-28 2019-04-04 Zenvision Pharma Llp NOVEL PHARMACEUTICAL COMPOSITION COMPRISING MEFENAMIC ACID AND OTHER ANALGESICS
US10525240B1 (en) 2018-06-28 2020-01-07 Sandler Scientific LLC Sino-nasal rinse delivery device with agitation, flow-control and integrated medication management system

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1026502A (en) * 1961-10-13 1966-04-20 Upjohn Co Improvements in or relating to steroids and the manufacture thereof
US4446140A (en) * 1981-12-10 1984-05-01 Nelson Research & Development Company Method and composition for treating mouth pain
DE3328401A1 (de) * 1983-08-05 1985-02-21 Merckle GmbH, 7902 Blaubeuren Injizierbare loesung zur behandlung von entzuendungen
US4851233A (en) 1986-10-06 1989-07-25 Warner-Lambert Company Sustained release formulations
US5064858A (en) 1988-08-17 1991-11-12 Spectrum Pharmaceutical Corporation Protected complex of procaine for the treatment of symptoms from narcotics addiction, tinnitus and Alzheimer's disease
ATE114472T1 (de) 1989-09-21 1994-12-15 American Cyanamid Co System des typs ''einmal täglich'' zur gepulsten minocyclinabgabe.
IE66933B1 (en) * 1990-01-15 1996-02-07 Elan Corp Plc Controlled absorption naproxen formulation for once-daily administration
IT1242642B (it) * 1990-04-17 1994-05-16 Alfa Wassermann Spa Formulazioni iniettabili contenenti naproxen sale sodico.
GB9121204D0 (en) 1991-10-04 1991-11-20 Euro Celtique Sa Medicament
SG42869A1 (en) * 1992-08-05 1997-10-17 Faulding F H & Co Ltd Pelletised pharmaceutical composition
US5609884A (en) * 1992-08-31 1997-03-11 G. D. Searle & Co. Controlled release naproxen sodium plus naproxen combination tablet
US5451409A (en) 1993-11-22 1995-09-19 Rencher; William F. Sustained release matrix system using hydroxyethyl cellulose and hydroxypropyl cellulose polymer blends
US5702723A (en) * 1994-08-02 1997-12-30 Griffin; David Multi-stage delivery system for ingestible medications or nutrients
TW483763B (en) 1994-09-02 2002-04-21 Astra Ab Pharmaceutical composition comprising of ramipril and dihydropyridine compound
US5547948A (en) 1995-01-17 1996-08-20 American Home Products Corporation Controlled release of steroids from sugar coatings
WO1996029986A1 (en) * 1995-03-29 1996-10-03 The Procter & Gamble Company Antitussive microcapsules

Also Published As

Publication number Publication date
AU742622B2 (en) 2002-01-10
PL336154A1 (en) 2000-06-05
EP0979087A1 (de) 2000-02-16
EP0979087B1 (de) 2003-11-12
ES2210754T3 (es) 2004-07-01
YU52999A (sh) 2002-06-19
HU225601B1 (en) 2007-05-02
DE19715594A1 (de) 1998-10-22
DK0979087T3 (da) 2004-03-08
NO994663D0 (no) 1999-09-24
RU2218180C2 (ru) 2003-12-10
HUP0003636A2 (hu) 2001-05-28
BR9808875A (pt) 2000-07-11
CA2285979A1 (en) 1998-10-22
AU7428698A (en) 1998-11-11
ATE253919T1 (de) 2003-11-15
CN1177589C (zh) 2004-12-01
NZ500262A (en) 2002-04-26
CN1252725A (zh) 2000-05-10
PL190863B1 (pl) 2006-02-28
KR100532647B1 (ko) 2005-12-02
HUP0003636A3 (en) 2001-12-28
US20010002999A1 (en) 2001-06-07
NO323022B1 (no) 2006-12-27
KR20010006348A (ko) 2001-01-26
TR199902396T2 (xx) 2000-01-21
JP2002503221A (ja) 2002-01-29
RS49620B (sr) 2007-08-03
HK1027505A1 (en) 2001-01-19
WO1998046235A1 (de) 1998-10-22
NO994663L (no) 1999-09-24
DE59810166D1 (de) 2003-12-18
CA2285979C (en) 2009-11-24
PT979087E (pt) 2004-03-31
US6929805B2 (en) 2005-08-16

Similar Documents

Publication Publication Date Title
AR012417A1 (es) COMPOSICIoN FARMACÉUTICA DE ADMINISTRACIoN ORAL Y PROCEDIMIENTO PARA SU PRODUCCION.
ES2170069T3 (es) 1-alfa-hidroxiprevitamina d para administracion oral.
CO5170471A1 (es) Tabletas de liberacion modificada que incluyen amoxilina y clavulanato de potasio
ATE252892T1 (de) Aus mehreren einzeleinheiten zusammengesetzte arzneimittel mit nicht-steroidalen wirkstoffen (nsaids)
IT1270594B (it) Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
MY126555A (en) Oral pharmaceutical extended release dosage form
AR035642A1 (es) Uso de una composicion de celecoxib para el alivio rapido del dolor
IT1245761B (it) Formulazioni farmaceutiche contenenti glicosaminoglicani assorbibili per via orale.
NO330947B1 (no) Anvendelse av farmasoytiske sammensetninger som inneholder okskarbazepin, i fastende tilstand
AR031682A1 (es) Composiciones farmaceuticas
BR9909672A (pt) uso de um composto medicinal ativo no preparo de um medicamento para o tratamento de hipertensão
ATE91409T1 (de) Schnelloesliche dosierungsformen.
KR880002515A (ko) 흡수 및 작용이 빠른 설린다크 또는 나트륨 설린다크와 염기의 혼합물
EE04606B1 (et) H+, K+-ATPaasi inhibiitori kasutamine ravimi valmistamiseks peroraalseks manustamiseks
BR9708706B1 (pt) composiÇço farmacÊutica para administraÇço intravenosa a um paciente
ES2184148T3 (es) Composicion farmaceutica a base de rheina o de diacerheina para ser administrada por via oral, rectal o cutanea (percutanea o transdermica), presentando una biodisponibilidad mejorada.
AR046036A1 (es) Composiciones de risedronato y metodos para su uso
HUP0000137A2 (hu) Szabályozott hatóanyag-felszabadulású analgetikumot tartalmazó gyógyszerkészítmény
AR035946A1 (es) Composiciones farmaceuticas estrogenicas para usar en el tratamiento de desordenes en mujeres perimenopausicas, menopausicas o posmenopausicas, y usos de dichas composiciones para la preparacion de medicamentos
YU36401A (sh) Farmaceutska kompozicija za stimulator osetljivosti na insulin sa modifikovanim ispuštanjem
AR009113A1 (es) UN PRODUCTO ANTICONCEPTIVO PARA DETENER LA OVULACIoN EN MUJERES DURANTE SU PERIODO DE ACTIVIDAD OVÁRICA
EP0302714A3 (en) Pharmaceutical composition for treatment of bone-wasting diseases
CO5251412A1 (es) Composicion farmaceutica de mirtazapina para administracion peroral con cubierta polimerica
ATE305784T1 (de) Medikament gegen dysmenorrhoe und premenstruelles syndrom enthaltend lidocain
SE8501312D0 (sv) Etoposide oral dosage form

Legal Events

Date Code Title Description
FG Grant, registration